About USAID Our Work Locations Policy Press Business Careers USAID Seal - Link to Home Page
 

Bureau for Global Health

>> Regional Overview >> Global Health Overview
  
 

Bureau for Democracy, Conflict and Humanitarian Assistance

Bureau for Economic Growth, Agriculture, and Trade

Bureau for Global Health

Bureau for Management

Bureau for Policy and Program Coordination

Global Development Alliance

International Partnerships

Summary Tables

Notified Levels:
FY 2002
FY 2003

Abbreviations & Acronyms

Last updated: Wednesday, 29-May-2002 18:53:11 EDT

 
  

THE DEVELOPMENT CHALLENGE: Investing in the health of the world's population serves U.S. national interests by contributing to global economic growth, a sustainable environment, and regional security. Recent evidence supports the linkages of good health to improvements in productivity and poverty reduction. High levels of disease can slow or even halt economic growth. Likewise, control of infectious diseases, good nutrition and stabilization of population size are essential to sustainable development; indeed, they are fundamentally interdependent. People can contribute more fully to the social and economic progress of their community and nation when they are well nourished, free from diseases, and given adequate information to make informed decisions about their own family size. Reduced population pressures also lower the risk of humanitarian crises in countries where population growth rates are highest. In addition to enhancing livelihoods of people overseas, protecting human health and nutrition in developing and transitional countries directly affects public health in the U.S. by preventing the spreads of diseases that know no borders. These concerns are articulated in the US Department of State foreign policy objectives for health and population. To that end, USAID serves as the chief implementing agency to carry out the U.S. government's mandates.

The rapid spread of HIV/AIDS in many parts of sub-Saharan Africa, South and Southeast Asia, and the Caribbean presents a special development challenge. By devastating the most productive members of society, the disease drains the country's human and financial resources. In recent years, the AIDS pandemic alone stands to reverse decades of life expectancy and other health gains in sub-Saharan Africa, contributing to weakened prospects for economic growth and civil society stimulation. In 2002, this incurable virus has reached a magnitude exceeding any historical ravage from a single disease. In response, the Administration has highlighted HIV/AIDS and infectious diseases as high priority global concerns and threats to U.S. national security.

In response to these challenges, USAID created the Bureau for Global Health (GH) to serve as the locus of technical leadership for USAID in health. GH is vested with primary responsibility for research contributing to overall USAID's strategic objectives in international health. It investigates and produces innovations and develops pilot projects for broad application. GH also draws on the most advanced knowledge in health technical matters and shares that knowledge with field missions, donors, and partners at all levels.

BUREAU FOR GLOBAL HEALTH PROGRAM: In order to serve the USAID strategic objectives for health, GH provides leadership and technical expertise in the areas of HIV/AIDS, infectious diseases, child survival, maternal health, nutrition, and family planning. As such, GH aligns USAID resources with identified public health and development needs, and influences the global health priorities of partners and stakeholders. GH becomes the repository for state-of-the-art thinking in biomedical, social science, and operational research. It produces results that can be disseminated and replicated at USAID missions throughout the world. GH also helps ensure compliance with congressional directives and legislative intentions, and develops mechanisms for overall program evaluation and performance measurement. The expansive perspective of USAID is critical given that diseases are borderless - TB being the most recent example - and USAID works to mitigate their negative impact before they become serious global health threats.

USAID programs in international health engage in the following five priority areas:

  • reducing HIV/AIDS transmission and mitigating its impact;
  • reducing deaths from infectious diseases of major public health importance;
  • increasing the use of key maternal health and nutrition interventions;
  • increasing the use of interventions to improve child health and nutrition; and
  • increasing the use of voluntary practices to reduce fertility and improve reproductive health.

GH's programs are primarily funded through the Child Survival and Health (CSH) Fund of the Development Assistance account. Field programs for HIV/AIDS and population receive additional support from other accounts, including the Economic Support Fund, Freedom Support Act, and Assistance to Eastern Europe and Baltic States. The FY 2003 request for the Bureau for Global Health is $304.8 million (including $3.8 Development Assistance Fund for Displaced Children & Orphan Fund), down from the FY 2002 level of $326.1 million. The FY 2003 funds will be allocated as follows:

  • $65.5 million (22%) for HIV/AIDS;
  • $35.8 million (12%) for infectious diseases;
  • $52.7 million (17%) for child survival and maternal health; and
  • $150.8 million (49%) for reduced fertility and improved reproductive health.

In the coming year, USAID will substantially increase the resources it devotes to HIV/AIDS programs. GH has already established a new Office of HIV/AIDS and begun to realign its programs and staffing to support its expanded efforts in this area. These expanded efforts seek to monitor the spread of HIV/AIDS in sub-Saharan Africa and other parts of the developing world and improve the quality of life of those infected and affected by the disease. GH will also continue with its commitment to reduce the incidence of TB, malaria and other major infectious diseases. More generally, USAID's efforts to improve health conditions in the developing world and stabilize population growth directly contribute to economic growth and political stability while at the same time helping to reduce environmental degradation. Improved health and nutrition are key contributors to increased economic productivity and the reduction of poverty.

GH addresses USAID's priority areas through a combination of technical support to the field, research and evaluation, and global leadership.

Field-Driven Program Design and Comprehensive Technical Support: GH has developed an innovative approach to program design that is rare in the development field. In contrast to typical practice, GH follows a field-driven, field-oriented and field-based approach to developing and testing new technologies and methodologies. This is especially important in the rapidly changing health field. The approach generally includes the following steps: (1) need or problem identification (to which field missions contribute); (2) product and program development; (3) field testing, validation, and refinement; (4) field marketing and scale up; and (5) institutionalization at the field mission level. This approach has a long history of success and has been instrumental in diffusing technologies and innovations from north to south and from south to south. GH supports its state-of-the-art design activities with comprehensive technical support that maximizes the chances for programmatic success. To this end, GH manages activities that incorporate and adapt experience and knowledge gained worldwide to support and complement mission health programs. Missions expect GH to provide them with state-of-the-art tools and technologies to apply to local problems, helping them to "push the technical envelope" and encouraging cost-effective approaches to programming. GH's support includes research, policy development, information, services, training, commodities, and evaluation.

Timely and Authoritative Research: GH is a leading sponsor of biomedical, operations, and behavioral research. GH promotes the development, testing and dissemination of new tools, technologies and approaches to combat critical health problems, strengthens program effectiveness, and surmounts policy constraints. GH has played a key role in developing new, cost-effective technologies such as oral rehydration salts, simple disease diagnosis, new contraceptive and birthing methods, and the use of vitamin A to enhance child survival. USAID supported studies that proved the linkage between provision of voluntary, confidential HIV counseling and testing and behavior change for at-risk population. In addition, GH has taken the lead in the development of indicators and methods to evaluate programmatic success and monitor trends in the health sector. Other donors and international agencies rely heavily on this work for policy development and program planning.

Global Leadership and High-Impact Partnerships: USAID is a recognized leader worldwide in health and exercises its leadership through the technical expertise of a multi-disciplinary staff. GH's global leadership focuses on fostering technical innovation, promoting policy dialogue and encouraging increased mobilization of resources for health activities. This leadership helps achieve USAID agency-wide results by increasing the opportunities for, and likelihood of, successful health programs and by encouraging the wider global community of countries, donors and non-governmental organizations to adopt new technologies and approaches and pursue USAID priorities and goals.

Recent USAID's success stories in Technical Support, Research, and Global Leadership:

  • USAID's HIV/AIDS strategy has supported programs that helped reduce HIV incidence in young adults, preventing, and even reversing major epidemics in some high prevalence countries. For example, USAID's support was instrumental in reducing HIV prevalence in 15-24 year olds in urban areas of Uganda by 50% and nationally by one-third.
     
  • In the past five years, USAID missions have helped developed tools such as HIV/AIDS education and intensive behavior change programs that reached over 30 million people and trained over 180,000 new HIV/AIDS counselors and educators worldwide.
     
  • Working collaboratively with international and national agencies as well as host governments, USAID has developed improved systems and tools for HIV/AIDS surveillance, resource management, and mechanisms to determine program progress and impact.
     
  • USAID has launched an intensive initiative to combat malaria that involves commercial marketing and distribution of insecticide-impregnated bed nets. The initiative promises to save tens of thousands of lives, especially of children, in the immediate years ahead.
     
  • Research supported by USAID demonstrate that supplemental vitamin A reduces mortality from all causes by 23%-34% in children under five years of age in populations where vitamin A deficiency is prevalent. As a result, routine vitamin A supplementation has become policy in much of the developing world.
     
  • USAID has been the leader in establishing national vitamin A programs in more than 50 countries, delivering over 100 million doses annually. The World Health Organization estimates that these programs are averting more than 240,000 child deaths each year.
     
  • USAID played a key role in establishing the Global Alliance for Vaccines and Immunization fund (GAVI), which aims to improve access and expand the use of vaccines, accelerate research and development, and make immunization coverage a centerpiece of international development. Of the total funding of $1 billion, USAID is expected to contribute $53 million in FY 2002.
     
  • USAID also led in the establishment of the Global TB Drug Facility. Through streamlining the standardization of drug products, bulk buying procurement system, and competitive bidding processes, the GDF has cut TB drug prices for a six-month course of treatment to $10, a 30% reduction compared to previous international drug prices. Sixteen countries have already been approved for GDF support.
     
  • USAID was instrumental in introducing safe injection technology for injectable contraceptives, which promises to improve safety for family planning clients and health workers, thereby expanding contraceptive coverage.
     
  • New partnerships were developed with the commercial sector to provide contraceptive protection to three million new couples, leading to less dependency on donor assistance for family planning services and ensuring sustainability of the program.
     

Plans to build upon these successes in FY 2003 are included in the Progress Data Sheet.

ONGOING PROGRAMS FOR WHICH NO FY2002 & FY2003 FUNDING IS RQUESTED: No programs will be deleted. However, given necessity for development choice, assistance for child survival and maternal health, vulnerable children, and infectious disease will decrease.

OTHER PROGRAM ELEMENTS: In addition to providing overall field technical support, 63 field missions address at least one of the five health priority areas in their programs through the GH field support mechanism. Approximately one third of the country-level health and population sector funds flow back to GH to utilize centrally-managed instruments for programming and implementation.

USAID also coordinates its population, health and nutrition programs with the Departments of Health and Human Services, Agriculture, State and Treasury, as well as with the Centers for Disease Control and Prevention, the White House and other bilateral and multilateral agencies, and non-governmental agencies. Increasingly, USAID is working with the private and commercial sector - industry and foundations - to take advantage of technical and financial synergies in facing the challenge to improve global health.

OTHER DONORS: USAID has exceptional relationships with key multilateral (e.g. U.N. Children Fund, U.N. Population Fund, Joint U.N. Program on HIV/AIDS, World Health Organization) and bilateral agencies (e.g. United Kingdom, Japan, Germany, Canada), private foundations (Gates, Packard, Hewlett), as well as with the public and non-profit sectors. USAID also plays a lead role in the development of The Global Fund to Fight HIV/AIDS, TB and Malaria, an entity dedicated to mobilize resources in the fight against the world's major infectious diseases. USAID brings its trademark technical expertise to these partnerships. Leveraging this contribution along with significant financial resources, the U.S. government has marked impact on health policy and programs at both the global and country levels.

USAID and the major partners in the health sector focus on the most pressing global health issues, including the HIV/AIDS pandemic, infectious diseases, child survival and maternal health and reproductive health. Despite having a different strategic approach toward development compared to United Nations Agencies and most other bilateral donors, which emphasize poverty alleviation over sustainable development, USAID has been able to achieve fruitful collaborations with partners to bring about health improvements for the world's population.

The following examples highlight the successful partnerships that have been forged with various organizations:

  • A senior Bureau staff member has been seconded to serve as the Transitional Support Secretariat Chair of The Global Fund to Fight HIV/AIDS, TB and Malaria. He's working with 38 members in the Fund's creation.
  • Global Alliance to Improve Nutrition (GAIN) is a collaborative effort to make competitive grants to developing countries in support of food fortification and other sustainable micronutrient interventions. The main players include UNICEF, Canadian International Development Agency, Bill and Melinda Gates Foundation, USAID and several private food companies.
  • In collaboration with other bilateral donors, USAID has been an active member of the UN Special Session on Children Preparatory Committees.
  • Addressing the issue of contraceptive commodity security, GH is active in UNFPA's Commodities Working Group, which strives to address the supply side of this global issue.
  • GH is working with the UN Foundation to secure matching funds for UN agencies to carry out collaborative safe motherhood initiatives. The first such program is currently in development in Nepal.

Program Data Sheets

  • 936-0011  New and Improved technologies and approached for contraceptive methods and family planning identified, developed, tested, evaluated and disseminated
  • 936-0012  Improved policy environment and increased global resources for family planning programs.
  • 936-0013  Enhance capacity for national programs (public, private, non-governmental organization and community-based institutions) to design, implement, finance, and evaluate sustainable family planning programs
  • 936-0014  Increased access to, quality of cost-effectiveness of, and motivation to use family planning, breastfeeding, and selected reproductive health information and services
  • 936-002  Increased use of key maternal health and nutrition interventions
  • 936-003  Increased use of key child health and nutrition interventions
  • 936-004  Increased use of improved, effective, and sustainable responses to reduce HIV transmission and to mitigate the impact of the HIV/AIDS pandemic
  • 936-005  Increased use of effective interventions to reduce the threat of infectious diseases of major public health importance

Star